Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.

The FDA has approved Vertex Pharmaceuticals' Journavx, a new pain medication that doesn't carry the risks of addiction and ...

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Reaching for a diet soda or artificially sweetened snack to lose weight or to enjoy a few more treats? A growing number of scientists believe that’s not a good idea.

FDA approves Zyn nicotine pouches, including 10 flavors, as a safer option for adult smokers. The decision marks the first FDA authorization for nicotine pouches, which are tobacco-free.

FDA approves Zyn nicotine pouches, including 10 flavors, as a safer option for adult smokers. The decision marks the first FDA authorization for nicotine pouches, which are tobacco-free. Advocates ...

The FDA also approved Netherlands-based Qiagen's (QIA.DE), opens new tab companion diagnostic device to identify patients eligible for the combination treatment. Lumakras is an oral drug designed ...